Article
Effects of molecular structural variants on serum Krebs von den Lungen-6 levels in sarcoidosis.
Journal of translational medicine - 11 Jul 2012
Shigemura Masahiko, Nasuhara Yasuyuki, Konno Satoshi, Shimizu Chikara, Matsuno Kazuhiko, Yamguchi Etsuro, Nishimura Masaharu
Abstract excerpt
BACKGROUND: Serum Krebs von den Lungen-6 (KL-6), which is classified as human mucin-1 (MUC1), is used as a marker of sarcoidosis and other interstitial lung diseases. However, there remain some limitations due to a lack of information on the factors contributing to increased levels of serum KL-6. This study was designed to investigate the factors contributing to increased levels of serum KL-6 by molecular...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
